T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Host Hotels & Resorts
HST
$12.1B
| $15.7M | ﹤0.01% |
1,024,992
+3,393
| +0.3% | +$52.1K |
|
1002
Incyte
INCY
$16.2B
| $15.7M | ﹤0.01% |
230,789
-246,251
| -52% | -$16.8M |
|
1003
Vale
VALE
$45.5B
| $15.6M | ﹤0.01% |
1,609,337
-6,408,914
| -80% | -$62.2M |
|
1004
Tarsus Pharmaceuticals
TARS
$2.08B
| $15.6M | ﹤0.01% |
383,902
-49,269
| -11% | -$2M |
|
1005
SharkNinja
SN
$16.1B
| $15.5M | ﹤0.01% |
156,194
+84,178
| +117% | +$8.33M |
|
1006
A.O. Smith
AOS
$10.2B
| $15.5M | ﹤0.01% |
235,739
-2,568
| -1% | -$168K |
|
1007
First Citizens BancShares
FCNCA
$25.5B
| $15.4M | ﹤0.01% |
7,869
-430
| -5% | -$841K |
|
1008
PennyMac Financial
PFSI
$6.44B
| $15.4M | ﹤0.01% |
154,413
+2,335
| +2% | +$233K |
|
|
MBX
1009
MBX Biosciences, Inc. Common Stock
MBX
$364M
| $15.4M | ﹤0.01% |
1,346,910
+245,994
| +22% | +$2.81M |
|
1010
J.M. Smucker
SJM
$11.5B
| $15.3M | ﹤0.01% |
155,308
-235
| -0.2% | -$23.1K |
|
1011
Solventum
SOLV
$12.7B
| $15.2M | ﹤0.01% |
201,007
-34
| -0% | -$2.58K |
|
1012
Ingredion
INGR
$8.09B
| $15.2M | ﹤0.01% |
112,294
+13,452
| +14% | +$1.82M |
|
1013
Toll Brothers
TOL
$13.8B
| $15.2M | ﹤0.01% |
133,171
-28,578
| -18% | -$3.26M |
|
1014
Red Rock Resorts
RRR
$3.65B
| $15.2M | ﹤0.01% |
291,949
+6,964
| +2% | +$362K |
|
1015
Globe Life
GL
$11.5B
| $15.2M | ﹤0.01% |
121,977
+1,831
| +2% | +$228K |
|
1016
HEICO Class A
HEI.A
$34.9B
| $15.1M | ﹤0.01% |
58,358
-782
| -1% | -$202K |
|
1017
Pinnacle West Capital
PNW
$10.5B
| $15.1M | ﹤0.01% |
168,595
+9,979
| +6% | +$893K |
|
1018
iShares MSCI ACWI ex US ETF
ACWX
$6.79B
| $15.1M | ﹤0.01% |
247,240
| – | – |
|
1019
AnaptysBio
ANAB
$655M
| $14.9M | ﹤0.01% |
673,171
-241,910
| -26% | -$5.37M |
|
|
BELFB
1020
Bel Fuse Class B
BELFB
$1.79B
| $14.9M | ﹤0.01% |
152,974
+148,424
| +3,262% | +$14.5M |
|
|
SION
1021
Sionna Therapeutics, Inc. Common Stock
SION
$1.01B
| $14.9M | ﹤0.01% |
861,238
-134,974
| -14% | -$2.34M |
|
|
FLOC
1022
Flowco Holdings Inc.
FLOC
$408M
| $14.9M | ﹤0.01% |
836,732
-475,468
| -36% | -$8.47M |
|
1023
Healthcare Realty
HR
$6.45B
| $14.9M | ﹤0.01% |
937,564
+701,854
| +298% | +$11.1M |
|
1024
CarMax
KMX
$8.97B
| $14.8M | ﹤0.01% |
219,596
+179
| +0.1% | +$12K |
|
1025
Huron Consulting
HURN
$2.44B
| $14.7M | ﹤0.01% |
106,901
+87,842
| +461% | +$12.1M |
|